Fisher & Paykel Healthcare Corporation Limited

ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)

Last Price

33.78

Today's Change

+0.48 (1.44%)

Day's Change

33.21 - 33.98

Trading Volume

438,403

Overview

Market Cap

19 Billion

Shares Outstanding

586 Million

Avg Volume

391,323

Avg Price (50 Days)

33.70

Avg Price (200 Days)

33.01

PE Ratio

58.24

EPS

0.58

Earnings Announcement

25-Nov-2025

Previous Close

33.30

Open

33.33

Day's Range

33.21 - 33.98

Year Range

28.55 - 35.76

Trading Volume

438,403

Price Change Highlight

1 Day Change

1.44%

5 Day Change

1.59%

1 Month Change

0.21%

3 Month Change

5.10%

6 Month Change

-2.93%

Ytd Change

-2.48%

1 Year Change

17.25%

3 Year Change

76.21%

5 Year Change

2.43%

10 Year Change

385.34%

Max Change

1290.12%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Instruments & Supplies

Description:

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment